CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
	Jun. 30, 2011	Jun. 30, 2010
Cash flows from operating activities:
Net loss	$ (2,882,818)	$ (5,282,600)
Adjustments to reconcile net loss to net cash used by operating activities:
Depreciation	7,441	16,623
Amortization of deferred financing costs		127,189
Amortization of intangible assets		356,722
Share-based payments included in operating expenses	524,408	2,351,305
Issuance of note payable to related parties as consideration for consulting services		300,000
Amortization of debt discount	245,222	36,958
Interest paid with common stock		286,026
Loss on extinguishment of debt	463,374	116,053
Changes in operating assets and liabilities, net of effects of business combination
Prepaid expenses and other current assets	(2,161)	(5,266)
Accounts payable	685,990	213,770
Accrued expenses and other liabilities	398,394	342,432
Net cash used in operating activities	(560,150)	(1,140,788)
Cash flows from investing activities:
Issuance of notes receivable	(35,000)
Other		1,388
Net cash used (provided) by investing activities:	(35,000)	1,388
Cash flows from financing activities:
Net proceeds from sale of common stock		937,586
Net proceeds from debentures	170,990	183,424
Advances on stock subscriptions	304,500
Proceeds from warrant exercises		869
Proceeds from sale of Series A convertible preferred stock	127,200
Principal payments on notes payable	(10,000)
Net cash provided by financing activities	592,690	1,121,879
Net change in cash and cash equivalents	(2,460)	(17,521)
Cash and cash equivalents, beginning of period	2,871	20,223
Cash and cash equivalents, end of period	411	2,702
Supplemental cash flow information
Cash paid for interest
Cash paid for income taxes
Noncash investing and financing activities
Shares issued in connection with settlement of liabilities	1,116,583	1,207,759
Issuance of common stock for Solcool acquisition		245,148
Accounts payable financed with Note Payable		141,047
Deferred financing costs paid with issuance of common stock		75,221
Original issue discount on notes payable		28,123
Beneficial conversion feature notes payable	$ 302,137